- Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis
-
Rouillard NA, Barnett SD, Zhang X, Kam L, Manikat R, Cheung R, Nguyen MH
- KMID: 2563422
- Clin Mol Hepatol.
- 2025 Jan;31(1):227-239.
- doi: 10.3350/cmh.2024.0564
Background/Aims: With the obesity pandemic, metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease and a leading cause of end-stage liver disease and liver-related deaths in the... -
- CITED
-
- Close
- SHARE
-
- Close
